Orexin is a member of neuropeptides which is involved in the central motor control. The substantia nigra pars compacta (SNc) is an important nucleus participating in motor control under both physiological and pathological conditions. Morphological studies reveal that orexinergic neurons located in lateral hypothalamus innervate the SNc. Both orexin-1 receptors (OX 1 R) and orexin-2 receptors (OX 2 R) are expressed in the SNc. To investigate the effects of orexins on SNc, single unit in vivo extracellular recordings and behavioral tests were performed in this study. Micro-pressure administration of orexin A and orexin B significantly increased the spontaneous firing rate of nigral DAergic neurons by 65.87 AE 7.73% and 90.49 AE 17.83%, respectively. The excitatory effects of orexin A on nigral DAergic neurons were mainly mediated by OX 1 R, while OX 2 R were involved in the increase in firing rate induced by orexin B. Selectively blocking OX 1 R and OX 2 R significantly decreased the firing rate of nigral DAergic neurons by 36.77 AE 6.26% and 32.04 AE 6.12%, respectively, which suggested that endogenous orexins modulated the spontaneous firing activity of nigral DAergic neurons. Finally, both elevated body swing test and haloperidol-induced postural behavioral test showed that unilateral microinjection of orexin A and orexin B induced significantly contralateral-biased swing and deflection behavior. Meanwhile, the specific OX 1 R and OX 2 R antagonists produced opposite effects. The present electrophysiological and behavioral studies suggested that orexins increased the firing activity of nigral DAergic neurons and participated in central motor control.
Orexins (hypocretins) consist of orexin A and orexin B, which are produced by orexinergic neurons in the lateral hypothalamic and perifornical area (Peyron et al. 1998; Sakurai et al. 1998) . Orexinergic fibers innervate all major brain regions. Two G protein coupled receptors, orexin-1 receptors (OX 1 R) and orexin-2 receptors (OX 2 R), are expressed widely in brain (Matsuki and Sakurai 2008; Kodadek and Cai 2010) . Orexins play important roles in central nervous system, including regulation of sleep and wakefulness, reward processing, energy homeostasis, and blood pressure (Xu et al. 2013; Chieffi et al. 2017) . Recently, Hu et al. (2015) reviewed the relationship between orexin system and central motor control. In addition, orexin system is involved in the manifestations of Parkinson's disease (PD) . Clinical trials revealed that the orexin levels in cerebrospinal fluid (CSF) (Drouot et al. 2003; Fronczek et al. 2007 ) and the number of orexinergic neurons in patients with PD are lower than control group (Thannickal et al. 2007; Wienecke et al. 2012) . Orexinergic neurons also decrease in PD model rats treated with 6-hydroxydopamine (6-OHDA), but the CSF orexin levels do not decline significantly (Cui et al. 2010) . Many studies demonstrated the protective effects of orexins on PD. Orexin A protects cellular model of PD via inducing hypoxia-inducible factor-1 a (Feng et al. 2014) , and protein kinase C and phosphoinositide 3-kinase signaling pathways are involved in this process (Pasban-Aliabadi et al. 2017) . Furthermore, orexin A improves motor performance in rotarod test and grip test in rat model of PD, accompanied by amelioration of cognition function (Hadadianpour et al. 2017) .
The substantia nigra pars compacta (SNc) plays crucial roles in basal ganglia circuit, which participates in central motor control. The selective degeneration of DAergic neurons in SNc is the basic pathological change in PD (Hornykiewicz 1975) . Many studies demonstrated the relationship between the substantia nigra and the orexin system. Morphological studies revealed that the orexinergic fibers are dense in SNc, while moderate in substantia nigra pars reticulata of normal rats (Peyron et al. 1998) . Recently, a similar distribution density is observed in both SNc and substantia nigra pars reticulata (Schmitt et al. 2012) . By contrast, Mondal et al. (1999) showed that no clear orexin-positive fiber is expressed in the SNc of obese rats. The expression density of two orexin receptors is different in many nuclei, but both OX 1 R (Hervieu et al. 2001) and OX 2 R (Cluderay et al. 2002) , as well as dense mRNA of both receptors are expressed in the substantia nigra (Marcus et al. 2001) .
Previous studies demonstrated that orexins exert different functions in the substantia nigra. Behavioral tests revealed that microinjection of orexin A into the SNc increases spontaneous physical activity in rats, which is involved in the regulation of obesity (Teske et al. 2014) . Lesions of nigral DAergic neurons caused by hypocretin2-saporin, which selectively kills neuron-expressed OX 2 R, increase wakeful time in rats (Gerashchenko et al. 2006) . However, up to now, the in vivo electrophysiological effects of orexins on nigral DAergic neurons remain unknown. In this study, we aimed to illuminate the in vivo electrophysiological effects of orexins on nigral DAergic neurons. We also observed the direct motor behavioral modulation of nigral orexins in rats.
Materials and methods

Animals
Adult male Wistar rats (210-280 g, Qingdao Marine Drug Institution, Shandong, China, research resource identifier: SCR_006288) were used for this experiment. Animals were housed in a temperature controlled (22 AE 1°C) room and maintained on a 12-h light/12-h dark cycle. Food and water were available at all time. All rats were identified by earmarks and numbered and using a table of random numbers divided into experimental and control groups. The investigators were blinded to experimental group, until the end of the experiment. Animal experiments were conducted according to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (United States). The protocol for animal usage in this study was approved by the National Science Foundation of China (No. 31671076, 2016) . A schematic diagram, with the numbers of rats in each group, depicted the experimental design for both electrophysiological and behavioral study (Fig. 1) .
In vivo extracellular single unit electrophysiological recordings Rats were anesthetized with urethane (1 g/kg, i.p.; supplemented as needed) and positioned gently in the stereotaxic apparatus. A heating pad was used to maintain rectal temperature at 36-38°C. According to the stereotaxic atlas (Paxinos and Watson 2007) , a craniotomy was performed at coordinates of 4.8-5.2 mm posterior and 1.8-2.5 mm lateral from the bregma.
Three-barrel microelectrodes were fastened at each end with metal tubing and prepared using a Stoelting pipette puller (model 51217; Stoelting, Wood Dale, IL, USA), which had a tip of 2-10 lm and a resistance of 10-20 MΩ. Afterward, the electrodes were stereotaxically positioned into the SNc. The recording barrel was filled with a commixture of 0.5 M sodium acetate and 2% pontamine sky blue. The other two micro-pressure ejection barrels connected to four-channel pressure injector (PM2000B; Micro Data Instrument, Inc., Plainfield, New Jersey, USA), respectively, contained (i) orexin A (0.01 mM) and vehicle (normal saline); (ii) orexin B (0.1 lM) and vehicle (normal saline); (iii) SB 334867 (0.1 lM) and vehicle [normal saline containing 1/100 000 dimethyl sulfoxide (DMSO)]; (iv) TCS OX2 29 ((2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-py ridinylmethyl)amino]-1-butanone hydrochloride) (0.01 mM) and vehicle (normal saline); (v) orexin A (0.01 mM) and SB 334867 (0.1 lM); (vi) orexin B (0.1 lM) and TCS OX2 29 (0.01 mM). According to the location and electrophysiological features, the spontaneous firing neurons were identified as nigral DAergic neurons. Drugs were ejected onto the surface of neurons with short pulse gas pressure (1500 ms, 5.0-15.0 psi). The recorded electrical signals were amplified by a microelectrode amplifier (Model 1700, A-M Systems, Carlsborg, WA USA) and displayed on a memory oscilloscope (VC-11; Nihon Kohden, Tokyo, Japan). The amplified electrical signals were passed through low (5000 Hz)-and high (1 Hz)-pass filters into a bioelectricity signal analyzer and computer. Spike parameters were pre-processed online and further analyzed offline using Micro 1401 and Spike 2 software (Cambridge Electronic Design Limited, Cambridge, UK) for spike data analysis. Drug infusion was performed only once for each recording and only one neuron was recorded in the same track. At least 5-min stable basal firing was collected from each neuron before drug ejection into nigral DAergic neurons. The frequency of basal firing was determined by the average frequency of 120 s baseline data before drug administration. The maximal change of frequency within 50 s following drug application was considered as drug effect. A change in firing rate was considered significant if the change in firing rate exceeded two standard deviations. The coefficient of variance (CV) is the ratio of the standard deviation of interspike interval to its mean.
Implantation of cannula
Rats were anesthetized with chloral hydrate (400 mg/kg, i.p.) and placed carefully in a stereotaxic frame. Stainless steel guide cannula (o.d., 0.4 mm; i.d., 0.3 mm) was implanted into the SNc (5.0 mm posterior, 2.1 mm lateral from the bregma, 7.0 mm ventral from the skull surface. The tips of cannula were 1 mm above the surface of SNc) on both sides. The cannulas were fixed to the skull with stainless steel screws and dental acrylic. Following surgery, the rats were put in blanket and warmed up with heating lamp. Acetaminophen (100 mg/kg, s.c.) was used to reduce pain and penicillin sodium (40 WU/kg, i.m.) was administrated to prevent infection. After 5 days of recovery, the rats were used for behavioral tests.
Elevated body swing test
Elevated body swing test (EBST) is a common method to evaluate asymmetrical motor behavior by measuring the frequency and direction of the swing behavior of rats (Borlongan et al. 1995) . The rats showing unbiased behavior were chosen for this test. The rat was placed in a transparent plastic cage (40 9 40 9 35 cm) for 10 min to adapt to the surrounding. Held 2 cm above the bottom of tail, the rat was elevated to 2 cm above the bottom of the cage. The body swing referred to the rat head with deviation of vertical axis more than 10°. Before every swing was recorded, the rat head must be suspended at a vertical axis. If the rat did not bend its head after being elevated over 5 s, the tail was gently pinched. Each test rat was recorded for 60 s.
Postural test
Haloperidol (0.25 mg/kg), a specific dopamine D 2 receptor antagonist, was administrated intraperitoneally to induce cataleptic behavior (Lorenc-Koci et al. 1996) . Ten minutes after haloperidol administration, a total volume of 0.2 lL of drug (same concentration as electrophysiological recordings) or vehicle was injected into the SNc through the guide cannula over 2 min. The injector cannula was left in place for an additional 1 min after microinjection. Based on the angle between the nose-back line and the back-tail line, the postural asymmetry was quantitatively scored as follows: 0, no fixed postural alteration; 1, < 30°; 2, 30-59°; 3, 60-89°; and 4, > 90°.
Histological controls
To verify the sites of electrophysiological recording, pontamine sky blue was ejected after electrophysiological experiments. In behavioral tests, the positions of the cannula were also examined. After deep anesthesia with chloral hydrate (600 mg/kg, i.p.), rats were perfused with normal saline and 4% paraformaldehyde solution transcardially in turn. Until the circulatory system filled with paraformaldehyde solution, the rats were decapitated to separate the brains. Brains were frozen and sectioned at 50 lm. All the recording and microinjection sites were verified under light microscope (Fig. 2a) . If the microinjection and recording sites were out of the SNc, the experimental data of rats were excluded from the data analysis. Only the rats with correct positions were included for further analysis. Totally, 140 rats were used in the present electrophysiological and behavioral experiments, and 12 rats (8.6%) were excluded from data analysis for the misplacement of microelectrodes.
Drugs and statistics
Orexin A (CAT #1455), orexin B (CAT #1456), SB 334867 (CAT #1960), and TCS OX2 29 (CAT #3371) were obtained from Tocris (Avonmouth, UK). Haloperidol (CAT #H1512) and pontamine sky blue (CAT #8679) were purchased from Sigma (St. Louis, MO, USA). DMSO (CAT #Amresco 0231) was purchased from Biosharp (Hefei, China).
Sample size for electrophysiological recording was calculated by pilot studies according to the formula for paired samples (Su et al. 2014) , while behavioral test was determined based on that of previous studies (Diao et al. 2017; Xue et al. 2010) . The data were expressed as mean AE SEM. No outlier (greater than three deviations from the mean) was found among the data. Paired t-test was used to compare the difference of firing rate before and after drug treatment. Before t-tests, Kolmogorov-Smirnov test was performed to determine if the data are normally distributed. Mann-Whitney test was used to determine the difference of the change in firing rate between two groups. The percentages of swing and the scores of catalepsy were analyzed by Kruskal-Wallis test followed by Mann-Whitney test. The level of significance was preset using a p value of 0.05.
Results
The spontaneous firing activities of nigral DAergic neurons display specific features. DAergic neurons show an obvious biphasic action potential with a long duration and a notch during rising phase, accompanied by a low frequency (< 8 Hz) (Grace and Bunney 1983; Fa et al. 2003) . GABAergic neurons in substantia nigra show faster firing rate (> 10 Hz) (Wilson et al. 1977 ) compared with DAergic neurons and display shorter action potential duration without notch (Fig. 2b) . The average firing frequency was 2.69 AE 0.12 Hz (ranging from 0.62 Hz to 7.94 Hz) in total 145 DAergic neurons recorded in this study, which was consistent with the average frequency of 2.9 AE 0.4 Hz in previous study (Rasmussen et al. 2007) .
Orexin A and orexin B increased the spontaneous firing rate of nigral DAergic neurons in normal rats First, we observed the effects of orexin A on the spontaneous firing activity of nigral DAergic neurons in vivo. Totally, 36 DAergic neurons were recorded in 15 rats with the average basal firing rate of 2.45 AE 0.23 Hz. After micro-pressure administration of 0.01 mM orexin A, the spontaneous firing rate was significantly increased from 2.11 AE 0.25 Hz to 3.20 AE 0.32 Hz (p = 0.000, Fig. 3a and b) in 25 out of the 36 neurons. The average increase was 65.87 AE 7.73%. In control group, normal saline did not change the firing rate significantly (basal: 2.54 AE 0.31 Hz; saline: 2.48 AE 0.33 Hz, average change: À2.83 AE 1.46%, n = 6, p = 0.133, Fig. 3b ). The increase in firing rate induced by orexin A showed negative correlation with the basal firing rate (r = À0.617, p = 0.001, Fig. 3c ). The firing pattern (CV) after administration of orexin A did not display any remarkable change in the present analytical method (basal: 0.74 AE 0.08; orexin A: 0.79 AE 0.09, n = 25, p = 0.081). In the remaining 11 nigral DAergic neurons, the change in firing rate was less than two standard deviations (basal: 3.01 AE 0.45 Hz; orexin A: 3.22 AE 0.44 Hz, n = 11).
To examine the effects of orexin B, we micro-pressure ejected 0.1 lM orexin B to the surface of DAergic neurons. In 15 rats, orexin B significantly increased the firing rate from 2.17 AE 0.23 Hz to 3.68 AE 0.26 Hz in 25 out of the 33 neurons (p = 0.000, Fig. 4a and b) . The average increase was 90.49 AE 17.83%. While, no significant difference was found after vehicle application (basal: 2.82 AE 0.23 Hz; saline: 2.79 AE 0.25 Hz, average change: À1.29 AE 1.8%, n = 5, p = 0.576, Fig. 4b ). We also observed that the level of orexin B-induced increase in firing rate was negatively correlated with the basal firing rate (r = À0.584, p = 0.002, Fig. 4c ). The firing pattern (CV) also did not change significantly (basal: 0.83 AE 0.12; orexin B: 0.92 AE 0.12, n = 25, p = 0.062).
In the rest of eight neurons, orexin B did not change the firing rate more than two standard deviations (basal: 2.82 AE 0.72 Hz, orexin B: 3.21 AE 0.81 Hz, n = 8). We compared the excitatory effects induced by orexin A and orexin B. The increase in firing rate between orexin A and orexin B did not show comparable difference (orexin A: 65.87 AE 7.73%, orexin B: 90.49 AE 17.83%, p = 0.713).
Endogenous orexins modulated the spontaneous firing of nigral DAergic neurons To investigate the effects of endogenous orexins on the tonic firing activity of nigral DAergic neurons, we micro-pressure injected SB 334867 (specific OX 1 R antagonist) or TCS OX2 29 (specific OX 2 R antagonist) on recorded neurons. Application of 0.1 lM SB 334867 significantly decreased the spontaneous firing rate from 2.99 AE 0.27 Hz to 1.86 AE 0.28 Hz (p = 0.000, Fig. 5a and b) in 21 out of the 28 neurons recorded from 9 rats. The average decrease was 36.77 AE 6.26%. In control group, vehicle (normal saline containing 1/100 000 DMSO) did not change the firing rate significantly (basal: 2.72 AE 0.56 Hz; vehicle: 2.74 AE 0.62 Hz, n = 5, p = 0.712, average change: 0.78 AE 4.25%). In another seven neurons, SB 334867 did not significantly change the firing rate.
Furthermore, after TCS OX2 29 (0.01 mM) administration, the spontaneous firing rate of nigral DAergic neurons was significantly decreased from 3.19 AE 0.43 Hz to 2.24 AE 0.41 Hz in 9 out of the 15 neurons from 6 rats (p = 0.003, average decrease: 32.04 AE 6.12%, Fig. 6a and b) . In control group, normal saline changed the firing rate from 2.80 AE 0.44 Hz to 2.94 AE 0.59 Hz (n = 5, p = 0.487, average change: 2.93 AE 5.39%). In the remaining six neurons, TCS OX2 29 did not change the firing rate significantly.
The inhibitory effects of SB 334867 (36.77 AE 6.26%) and TCS OX2 29 (32.04 AE 6.12%) were not significantly different (p = 0.700), which suggested that OX 1 R and OX 2 R exerted similar effects in endogenous orexins-induced modulation of DAergic neuron firing activities.
Orexin A and orexin B increased the spontaneous firing rate of nigral DAergic neurons via OX 1 R and OX 2 R, respectively We next examined the receptor mechanisms involved in the excitatory effects of orexin A and orexin B on nigral DAergic neurons. In six orexin A (0.01 mM) excitatory neurons from three rats, the second time application of orexin A subsequent to SB 334867 (0.1 lM) only increased the spontaneous firing rate by 14.06 AE 2.18% (basal: 1.78 AE 0.39 Hz; orexin A + SB 334867: 2.03 AE 0.43 Hz), which was significantly weaker than the average increase of 51.51 AE 4.78% (n = 6, p = 0.004, Fig. 7a and b ) of orexin A alone (basal: 2.21 AE 0.39 Hz, orexin A: 3.28 AE 0.52 Hz).
In the same way, orexin B and TCS OX2 29 were co-applied to investigate the contribution of OX 2 R in the excitatory effects induced by orexin B. In six orexin B (0.1 lM) excitatory neurons recorded from four rats, the first administration of orexin B alone increased the firing rate by 69.60 AE 24.00% (basal: 1.88 AE 0.34 Hz; orexin B: 2.86 AE 0.28 Hz). While, co-application of orexin B and TCS OX2 29 (0.01 mM) changed the firing rate from 1.47 AE 0.41 Hz to 1.53 AE 0.44 Hz, with an average increase of 0.70 AE 8.38%. There was significant difference in the average increase in firing rate between co-application of orexin B with TCS OX2 29 and application of orexin B alone (n = 6, p = 0.010, Fig. 8a and b) .
Behavioral effects of unilateral microinjection of orexins into the SNc in rats
Above electrophysiological experiments suggested that orexins modulated the spontaneous firing activity of nigral DAergic neurons at single cellular level. Further studies were performed to observe the possible modulation of nigral orexins on motor behavior in awake rats.
In EBST, total 34 rats were randomly divided into seven groups. Unilateral microinjection of normal saline into the SNc did not induce marked biased swing (contralateral-biased swing 50.0 AE 4.5%, n = 5). Unilateral microinjection of orexin A (0.01 mM) significantly increased the percentage of contralateral-biased swing (88.0 AE 7.3%, n = 5, p = 0.014). Coapplication of SB 334867 (0.1 lM) abolished the behavioral effects of orexin A. When the mixture of orexin A and SB 334867 were microinjected into the SNc, the percentage of contralateral-biased swing changed to 48.0 AE 3.7% (n = 5, p = 0.011 compared with orexin A group, Fig. 9a ). Orexin B (0.1 lM) unilateral microinjection also significantly increased the percentage of contralateral-biased swing (95.0 AE 2.2%, n = 6, p = 0.008 compared with vehicle group). This effect was attenuated by co-application of 0.01 mM TCS OX2 29 (contralateral-biased swing: 55.0 AE 2.9%, n = 4, p = 0.016 compared with orexin B group, Fig. 9b ). While, unilateral microinjection of SB 334867 or TCS OX2 29 alone significantly increased the percentage of ipsilateral-biased swing to 92.5 AE 4.8% (n = 4, p = 0.013) and 88.0 AE 5.8% (n = 5, p = 0.008), respectively ( Fig. 9a and b) .
Next, haloperidol was injected intraperitoneally to perform postural test in total 42 rats. In the presence of haloperidol, unilateral microinjection of normal saline into the SNc did not lead to fixed deflection posture in rats. However, unilateral administration of orexin A induced significantly contralateral deflection posture during 60 min, which was suppressed by co-administration of SB 334867. Orexin B also caused similar contralateral deflection posture, which was blocked by TCS OX2 29. After systemic administration of haloperidol, microinjection of SB 334867 or TCS OX2 29 alone induced significant ipsilateral deflection compared to control group. Figure 10 summarized the effects of nigral orexins on postural behavior.
Discussion
Orexins excite nigral DAergic neurons via OX 1 R and OX 2 R It is well known that orexin is a kind of excitatory neuropeptides in central nervous system. For example, orexins excite histaminergic neurons of the tuberomammillary nucleus through activating sodium-calcium exchanger (Eriksson et al. 2001) . Orexin A depolarizes lateral vestibular neurons and then improves vestibular-related motor behaviors (Zhang et al. 2011) . In addition, orexins also exert excitatory effects in locus coeruleus (Ivanov and Aston-Jones 2000) , arcuate nucleus (Burdakov et al. 2003) , and nucleus accumbens shell (Mukai et al. 2009 ). The present in vivo extracellular recordings revealed significant excitatory effects of orexin A and orexin B on nigral DAergic neurons. However, inconsistent with present finding, Korotkova et al. (2002) proposed that orexins do not affect the firing activity of DAergic neurons of SNc using in vitro brain slice of juvenile rats. One of the possible reasons for the discrepancy between Korotkova's and our studies is probably the age of the rats used. It is known that the pacemaker activity of DAergic neurons is relied on the intrinsic membrane characteristics. The expression of ion channels in nigral DAergic neurons is developed with growth, including the increased expression of Cav 1.3 (Dufour et al. 2014 ). Therefore, the ionic basis of firing activity in nigral DAergic neurons may be gradually altered from Na + channels to L-type Ca 2+ channels during growing (Sulzer and Schmitz 2007) . In adult rats, DAergic neurons are driven by somatodendritic L-type Ca 2+ channels, hyperpolarization-activated and cyclic nucleotide-gated cation channels, and Ca 2+ -activated SK K + channels. It has been reported that it is Ca 2+ rather than Na + that is responsible for the excitatory effects of orexins in many neurons (Kukkonen 2017) . For instance, orexins elevate intracellular Ca 2+ in human embryonic kidney 293 cells (Wang et al. 2014 ). Orexin A increases the level of intracellular Ca 2+ through L-type Ca 2+ channel in retinal ganglion cells (Liu et al. 2015; Wang et al. 2017) and prefrontal cortex neurons (Xia et al. 2009 ). Thus, we presumed that the changed ionic mechanisms may contribute to the different effects of orexins between juvenile and adult rats. To fully address these issues, one may need to propose the ionic mechanisms of orexins on DAergic neurons. Secondly, this study was performed in intact rats with the neuronal circuits well protected comparing with brain slice. Blume et al. (2018) found that SB 334867 induces opposing effects on immobility between adolescent and adult rats. The different neuronal networks may underlie the orexin receptor antagonist-induced different responses. In addition, the expression of neurotransmitter receptors may be developed during the lifetime. Our previous study suggests that the expression of OX 1 R in pallidal neurons starts from postnatal 14 days (Xue et al. 2016) . Similar results were found in mouse testis, in which the OX 1 R and orexin A are gradually increased from birth to adulthood (Joshi and Singh 2017) . However, in hypothalamus, the expressions of OX 1 R and OX 2 R are maximal at birth and progressively decrease with growth (Van Den Pol et al. 2001) . More studies should be done to explore the possible development of OX 1 R and OX 2 R in the SNc.
To investigate the receptor mechanisms of orexins-induced excitatory effects on nigral DAergic neurons, we applied orexins together with the specific receptor antagonists. Most of orexin A-induced excitatory effect was attenuated by SB 334867, which indicates that exogenous orexin A mainly binds OX 1 R in nigral DAergic neurons. Furthermore, coapplication of TCS OX2 29 and orexin B completely suppressed the excitatory effects of orexin B, suggesting that exogenous orexin B excites DAergic neurons through OX 2 R.
Endogenous orexins are involved in the modulation of the spontaneous firing activity of nigral DAergic neurons In this study, application of the specific OX 1 R or OX 2 R antagonist decreased the firing rate of DAergic neurons, illustrating that endogenous orexins are involved in the modulation of the spontaneous firing activity. It is demonstrated that endogenous orexins play important roles in central nervous system. Previous studies indicated that endogenous orexins regulate the firing activities of subthalamic neurons (Sheng et al. 2018) , hippocampal CA1 neurons , and globus pallidus neurons (Xue et al. 2016) . Furthermore, endogenous orexins modulate motor performance under motor challenge conditions. Microinjection of SB 334867 or TCS OX2 29 into the hypoglossal nucleus decreases the tonic genioglossus activity, which suggests the involvement of endogenous orexins in the regulation of genioglossus muscle activity in rats . In addition, endogenous orexins also play important roles in food intake (Terrill et al. 2016 ) and acute stress (Grafe et al. 2017) .
The firing activity of DAergic neurons is slower in old mice than younger mice, which is involved in the declined motor behavior in the old population (Branch et al. 2014) . Good et al. (2011) suggests that the electrophysiological characteristics of DAergic neurons change before the appearance of motor symptoms in a mice model of PD. Alpha-syn over-expression-induced deterioration of DAergic neurons and subsequent motor behaviors in Drosophila larvae are alleviated by activation of DAergic neurons (Qi et al. 2017) . Furthermore, the electrophysiological activity of nigral DAergic neurons is involved in the regulation of TH gene expression (Aumann and Horne 2012) . The dopamine content in the striatum is associated with the transformation of firing pattern of DAergic neurons (Tepper and Lee 2007) . To some extent, the survival of DAergic neurons in the SNc depends on the excitatory stimulation (Michel et al. 2013) . It is well known that the orexin level in CSF is declined in PD. According to this study, revealing the involvement of endogenous orexins in spontaneous firing activity of nigral DAergic neurons, we hypothesized that the decline of orexins under parkinsonian state may be a contributor of the implicated firing activity of DAergic neurons.
Orexins regulate motor behavior in the SNc
There is a close relationship between orexinergic system and central motor control. For example, application of orexin A in the hypothalamic paraventricular nucleus increases the spontaneous physical activity (Kiwaki et al. 2004) . Administration of orexin A in the SNc and rostral lateral hypothalamic area also increases movement in rats (Kotz et al. 2006) . Microinjection of orexin A in lateral vestibular nucleus improves vestibular-related motor behaviors. Orexin A activates gigantocellular reticulospinal neurons and participates in the gigantocellular reticular nucleus mediated motor modulation (Yang et al. 2017) . Consistent with above studies, our present behavioral tests suggest that orexins excited nigral DAergic neurons and subsequently activated motor pathway of basal ganglia in normal rats, while orexin receptor antagonists exerted opposite effects. Catalepsy induced by systemic application of haloperidol mimics hypokinesia of PD, considered as a model of PD (LorencKoci et al. 1996; Diao et al. 2017) . Microinjection of orexins into the SNc improved catalepsy and akinesia caused by haloperidol. The present finding suggests that orexins in the SNc may contribute to central motor control under parkinsonian state. Consistently, previous study demonstrates that intracerebroventricular injection of orexin A modifies the motor dysfunction in PD model rats (Hadadianpour et al. 2017 ).
In conclusion, our present in vivo single unit recordings indicated that exogenous orexin A increased the firing rate of nigral DAergic neurons mainly via OX 1 R, while exogenous orexin B exerted the excitatory effects through OX 2 R. Endogenous orexins participated in the modulation of the spontaneous firing activity of nigral DAergic neurons. Finally, both EBST and postural behavioral tests demonstrated that the SNc is one of the nuclei involved in orexinsmediated central motor control.
